How A3IS works
Discover our Anti-bacterial, Anti-fungal, Anti-viral and Intracellular Stimulation Platform Technology, A3IS.
Our industry and research partners
Nektr has partnered with industry leaders and research institutes to maximise the benefits of our platform technology, A3IS.
If you are interested in joining our multi-disciplinary collaboration group please feel free to contact us.
Where did the discovery come from?
Inspired by the antimicrobial properties of honey, our team of research scientists developed a technology with proven success in combatting several forms of bacterial, fungal and viral pathogens.
Over 15 years of extensive validation has demonstrated our technology’s broad application potential in the human dermatology sector among others. A3IS is a unique, patented platform technology with the ability to generate a sustained and tailored release of hydrogen peroxide.
Mechanism of Action
The sustained low dose release of hydrogen peroxide has resulted in the complete and irreversible kill of all pathogens tested to date. Hydrogen peroxide has been used as a biocide for centuries. Nektr Technologies have developed a system that can be tailored to produce hydrogen peroxide at a therapeutic level to combat various forms of infection.
Do you have questions about Nektr or our technology? Connect with us using the details below or get in touch by filling out the form. We would be happy to answer your questions!
Finisklin Business & Technology Park,
Sligo, Ireland, F91 HF66